Literature DB >> 17381073

Ala657 and conserved active site residues promote fibroblast activation protein endopeptidase activity via distinct mechanisms of transition state stabilization.

Sarah A Meadows1, Conrad Yap Edosada, Mark Mayeda, Thuy Tran, Clifford Quan, Helga Raab, Christian Wiesmann, Beni B Wolf.   

Abstract

Fibroblast activation protein (FAP) and dipeptidyl peptidase-4 (DPP-4) are highly homologous serine proteases of the prolyl peptidase family and therapeutic targets for cancer and diabetes, respectively. Both proteases display dipeptidyl peptidase activity, but FAP alone has endopeptidase activity. FAP Ala657, which corresponds to DPP-4 Asp663, is important for endopeptidase activity; however, its specific role remains unclear, and it is unknown whether conserved DPP-4 substrate binding residues support FAP endopeptidase activity. Using site-directed mutagenesis and kinetic analyses, we show here that Ala657 and five conserved active site residues (Arg123, Glu203, Glu204, Tyr656, and Asn704) promote FAP endopeptidase activity via distinct mechanisms of transition state stabilization (TSS). The conserved residues provide marked TSS energy for both endopeptidase and dipeptidyl peptidase substrates, and structural modeling supports their function in binding both substrates. Ala657 also stabilizes endopeptidase substrate binding and additionally dictates FAP reactivity with transition state inhibitors, allowing tight interaction with tetrahedral intermediate analogues but not acyl-enzyme analogues. Conversely, DPP-4 Asp663 stabilizes dipeptidyl peptidase substrate binding and permits tight interaction with both transition state analogues. Structural modeling suggests that FAP Ala657 and DPP-4 Asp663 confer their contrasting effects on TSS by modulating the conformation of conserved residues FAP Glu204 and DPP-4 Glu206. FAP therefore requires the combined function of Ala657 and the conserved residues for endopeptidase activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17381073     DOI: 10.1021/bi062227y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

Review 1.  The role of fibroblast activation protein in health and malignancy.

Authors:  Allison A Fitzgerald; Louis M Weiner
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 2.  Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein.

Authors:  Roger Yazbeck; Simone E Jaenisch; Catherine A Abbott
Journal:  Protoplasma       Date:  2017-06-16       Impact factor: 3.356

3.  Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents.

Authors:  Minfeng Chen; Xueping Lei; Changzheng Shi; Maohua Huang; Xiaobo Li; Baojian Wu; Zhengqiu Li; Weili Han; Bin Du; Jianyang Hu; Qiulin Nie; Weiqian Mai; Nan Ma; Nanhui Xu; Xinyi Zhang; Chunlin Fan; Aihua Hong; Minghan Xia; Liangping Luo; Ande Ma; Hongsheng Li; Qiang Yu; Heru Chen; Dongmei Zhang; Wencai Ye
Journal:  J Clin Invest       Date:  2017-08-28       Impact factor: 14.808

Review 4.  Invading one step at a time: the role of invadopodia in tumor metastasis.

Authors:  H Paz; N Pathak; J Yang
Journal:  Oncogene       Date:  2013-09-30       Impact factor: 9.867

5.  Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.

Authors:  Angélica M Santos; Jason Jung; Nazneen Aziz; Joseph L Kissil; Ellen Puré
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

6.  Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design.

Authors:  Kyung N Lee; Kenneth W Jackson; Simon Terzyan; Victoria J Christiansen; Patrick A McKee
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

7.  Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice.

Authors:  Ming-Hui Fan; Qiang Zhu; Hui-Hua Li; Hyun-Jeong Ra; Sonali Majumdar; Dexter L Gulick; Jacob A Jerome; Daniel H Madsen; Melpo Christofidou-Solomidou; David W Speicher; William W Bachovchin; Carol Feghali-Bostwick; Ellen Puré
Journal:  J Biol Chem       Date:  2015-12-09       Impact factor: 5.157

8.  A Single Second Shell Amino Acid Determines Affinity and Kinetics of Linagliptin Binding to Type 4 Dipeptidyl Peptidase and Fibroblast Activation Protein.

Authors:  Gisela Schnapp; Yvette Hoevels; Remko A Bakker; Patrick Schreiner; Thomas Klein; Herbert Nar
Journal:  ChemMedChem       Date:  2020-10-21       Impact factor: 3.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.